Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Collegium Pharmaceutical (COLL) stock

Learn how to easily invest in Collegium Pharmaceutical stock.

Collegium Pharmaceutical, Inc
NASDAQ: COLL - USD
DRUG MANUFACTURERS-SPECIALTY & GENERIC
$0
-

Collegium Pharmaceutical, Inc is a drug manufacturers-specialty & generic business based in the US. Collegium Pharmaceutical shares (COLL) are listed on the NASDAQ and all prices are listed in US Dollars. Collegium Pharmaceutical employs 234 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Collegium Pharmaceutical

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – COLL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Collegium Pharmaceutical stock price (NASDAQ: COLL)

Use our graph to track the performance of COLL stocks over time.

Collegium Pharmaceutical shares at a glance

Information last updated 2021-07-23.
Latest market close$23.89
52-week range$15.66 - $26.91
50-day moving average $23.38
200-day moving average $23.45
Wall St. target price$29.57
PE ratio 21.3497
Dividend yield N/A (0%)
Earnings per share (TTM) $1.18

Buy Collegium Pharmaceutical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Collegium Pharmaceutical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Collegium Pharmaceutical price performance over time

Historical closes compared with the close of $23.89 from 2021-05-28

1 week (2021-07-15) N/A
1 month (2021-06-25) -5.50%
3 months (2021-04-26) 2.75%
6 months (2021-01-22) N/A
1 year (2020-07-22) N/A
2 years (2019-07-22) N/A
3 years (2018-07-22) N/A
5 years (2016-07-22) N/A

Is Collegium Pharmaceutical under- or over-valued?

Valuing Collegium Pharmaceutical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Collegium Pharmaceutical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Collegium Pharmaceutical's P/E ratio

Collegium Pharmaceutical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, Collegium Pharmaceutical shares trade at around 21x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Collegium Pharmaceutical's EBITDA

Collegium Pharmaceutical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $140.7 million.

The EBITDA is a measure of a Collegium Pharmaceutical's overall financial performance and is widely used to measure a its profitability.

Collegium Pharmaceutical financials

Revenue TTM $321.2 million
Operating margin TTM 22.53%
Gross profit TTM $240.5 million
Return on assets TTM 7.06%
Return on equity TTM 26.98%
Profit margin 13.06%
Book value $4.83
Market capitalisation $886.5 million

TTM: trailing 12 months

Shorting Collegium Pharmaceutical shares

There are currently 4.2 million Collegium Pharmaceutical shares held short by investors – that's known as Collegium Pharmaceutical's "short interest". This figure is 3.3% down from 4.3 million last month.

There are a few different ways that this level of interest in shorting Collegium Pharmaceutical shares can be evaluated.

Collegium Pharmaceutical's "short interest ratio" (SIR)

Collegium Pharmaceutical's "short interest ratio" (SIR) is the quantity of Collegium Pharmaceutical shares currently shorted divided by the average quantity of Collegium Pharmaceutical shares traded daily (recently around 274269.22069417). Collegium Pharmaceutical's SIR currently stands at 15.27. In other words for every 100,000 Collegium Pharmaceutical shares traded daily on the market, roughly 15270 shares are currently held short.

However Collegium Pharmaceutical's short interest can also be evaluated against the total number of Collegium Pharmaceutical shares, or, against the total number of tradable Collegium Pharmaceutical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Collegium Pharmaceutical's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Collegium Pharmaceutical shares in existence, roughly 120 shares are currently held short) or 0.1383% of the tradable shares (for every 100,000 tradable Collegium Pharmaceutical shares, roughly 138 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Collegium Pharmaceutical.

Find out more about how you can short Collegium Pharmaceutical stock.

Collegium Pharmaceutical share dividends

We're not expecting Collegium Pharmaceutical to pay a dividend over the next 12 months.

Collegium Pharmaceutical share price volatility

Over the last 12 months, Collegium Pharmaceutical's shares have ranged in value from as little as $15.66 up to $26.91. A popular way to gauge a stock's volatility is its "beta".

COLL.US volatility(beta: 0.95)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collegium Pharmaceutical's is 0.9548. This would suggest that Collegium Pharmaceutical's shares are less volatile than average (for this exchange).

Collegium Pharmaceutical overview

Collegium Pharmaceutical, Inc. , a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc.

Frequently asked questions

What percentage of Collegium Pharmaceutical is owned by insiders or institutions?
Currently 1.206% of Collegium Pharmaceutical shares are held by insiders and 111.49% by institutions.
How many people work for Collegium Pharmaceutical?
Latest data suggests 234 work at Collegium Pharmaceutical.
When does the fiscal year end for Collegium Pharmaceutical?
Collegium Pharmaceutical's fiscal year ends in December.
Where is Collegium Pharmaceutical based?
Collegium Pharmaceutical's address is: 100 Technology Center Drive, Stoughton, MA, United States, 02072
What is Collegium Pharmaceutical's ISIN number?
Collegium Pharmaceutical's international securities identification number is: US19459J1043
What is Collegium Pharmaceutical's CUSIP number?
Collegium Pharmaceutical's Committee on Uniform Securities Identification Procedures number is: 19459J104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site